Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
NASOBOL Inhalo Brausetabl 30 Stk
Drug
Nasobol Inhalo, Brausetabletten zur Herstellung eines Dampfs zur Inhalation
Atemwegserkrankungen
12.03.3. – antibacterial agent
HAM – Human medicine
BRTDI – inhalation vapour, effervescent tablet
S – synthetic products for human use
D – Dispensed following expert advice (D)
Z – approved
6/3/2003
12/31/9999
Dosage strength
Nasobol Inhalo, Brausetabletten zur Herstellung eines Dampfs zur Inhalation
Atemwegserkrankungen
01
Z – approved
Package
7680557370141
In trade from / since 6/3/2003
A/R – Authorised / referenced
30 tablet(s)
014
Z – approved
Declaration
Component
8.5 mg cineolum
9.2 mg levomentholum
7.9 mg rosmarini aetheroleum
4.2 mg thymi aetheroleum
9.2 mg levomentholum
7.9 mg rosmarini aetheroleum
4.2 mg thymi aetheroleum
lavandulae aetheroleum
sorbitolum
maltodextrinum
acidum citricum
calcii carbonas
mannitolum
magnesii subcarbonas ponderosus
talcum
aromatica
alcohol benzylicus
citralum
citronellolum
silica colloidalis anhydrica
limonis aetheroleum
sorbitolum
maltodextrinum
acidum citricum
calcii carbonas
mannitolum
magnesii subcarbonas ponderosus
talcum
aromatica
alcohol benzylicus
citralum
citronellolum
silica colloidalis anhydrica
limonis aetheroleum
Authorisation holder
7601001394834
Spirig HealthCare AG
Industriestrasse 30
4622 Egerkingen (SO)
Industriestrasse 30
4622 Egerkingen (SO)
Date of revision of the text
2/1/2026
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.